𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The amplified WWP1 gene is a potential molecular target in breast cancer

✍ Scribed by Ceshi Chen; Zhongmei Zhou; Jeffrey S. Ross; Wei Zhou; Jin-Tang Dong

Publisher
John Wiley and Sons
Year
2007
Tongue
French
Weight
454 KB
Volume
121
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The amplification of the q21 band of chromosome 8 (8q21) occurs in a large percentage of breast cancers. WWP1, an HECT domain‐containing ubiquitin E3 ligase located in the 8q21 region, negatively regulates the TGF‐β tumor suppressor pathway. To characterize the role of WWP1 in breast cancer, we analyzed WWP1 gene dosage and expression level as well as WWP1's function. A copy number gain of WWP1 was found in 51% (18/35) of breast cancer cell lines and in 41% (17/41) of primary breast tumors. Expression of WWP1 mRNA was analyzed with real‐time RT‐PCR, Northern blot, and Western blot. WWP1 mRNA is up‐regulated in 58% (19/33) of breast cancer cell lines, and overexpression of WWP1 is significantly correlated with a gene copy number gain. In a panel of cDNA from primary breast tumors and normal tissues, expression of WWP1 in tumors is significantly higher than that in normal tissues. Functionally, RNAi‐mediated WWP1 knockdown significantly induced cell growth arrest and apoptosis in the MCF7 and HCC1500 breast cancer cell lines. Consistently, WWP1 inhibition activated caspases. Forced overexpression of WWP1 by the lentiviral system in 2 immortalized breast epithelial cell lines MCF10A and 184B5 promoted cell proliferation. These results suggest that genomic aberrations of WWP1 may contribute to the pathogenesis of breast cancer. © 2007 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Promoter methylation of the PTEN gene is
Promoter methylation of the PTEN gene is a common molecular change in breast cancer
✍ Jose M. García; Javier Silva; Cristina Peña; Vanesa Garcia; Rufo Rodríguez; Migu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 1 views

## Abstract About 25–50% of women with Cowden disease, a syndrome associated with germ‐line mutations of the __PTEN__ gene (at 10q23), develop breast cancer (BC), but __PTEN__ mutations have been found in only 5% of sporadic BCs. However, 29–48% of BCs display loss of heterozygosity in 10q23, and a

Rcl is a novel ETV1/ER81 target gene upr
Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors
✍ Sook Shin; Denis G. Bosc; James N. Ingle; Thomas C. Spelsberg; Ralf Janknecht 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 381 KB 👁 1 views

## Abstract ETV1 (ER81) is a transcription factor that can be activated by HER2/Neu, a proto‐oncoprotein often overexpressed in metastatic breast tumors. Here, we demonstrate that ETV1 downregulation suppresses proliferation of HER2/Neu‐positive MDA‐MB‐231 breast cancer cells in vitro and tumor for

HDLG5/KIAA0583, encoding a MAGUK-family
HDLG5/KIAA0583, encoding a MAGUK-family protein, is a primary progesterone target gene in breast cancer cells
✍ Sami Purmonen; Tytti M. Ahola; Pasi Pennanen; Nickolai Aksenov; Ya-Hua Zhuang; P 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB

## Abstract The steroid hormone progesterone is known to have profound effects on growth and differentiation of normal and malignant breast epithelial cells. The biologic actions of progesterone are exerted through the nuclear progesterone receptor‐mediated control of target gene transcription. We

The insulin-like growth factor I recepto
The insulin-like growth factor I receptor gene is the target for the 15q26 amplicon in breast cancer
✍ Anna Almeida; Martine Muleris; Bernard Dutrillaux; Bernard Malfoy 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB 👁 1 views

We report the amplification and overexpression of the IGFlR (insulin-like growth factor I receptor) gene in primary breast cancers with an amplification of band I5q26. The involvement of IGFIR, which may vary in frequency from 2-3% in unseleaed tumor series to more than 10% in breast cancers with hs

New nonsense mutation in the breast canc
New nonsense mutation in the breast cancer-1 gene in a French site-specific breast cancer family
✍ V Laplace-Marieze; N Presneau; C Girodet; V Vidal; C Vaurs; P Rio; Y-J Bignon 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB 👁 3 views

Duchenne muscular dystrophy (DMD) is an X-linked degenerative disorder of muscle, caused by gross rearrangements by the dystrophin gene in two-thirds of cases. The remaining one-third of patients may carry more subtle mutations that are difficult to detect because of the large size and complexity of

Insulin receptor substrate 1 is a target
Insulin receptor substrate 1 is a target for the pure antiestrogen ICI 182,780 in breast cancer cells
✍ Michele Salerno; Diego Sisci; Loredana Mauro; Marina A. Guvakova; Sebastiano And 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB

The pure antiestrogen ICI 182,780 inhibits insulin-like growth factor (IGF)-dependent proliferation in hormoneresponsive breast cancer cells. However, the interactions of ICI 182,780 with IGF-I receptor (IGF-IR) intracellular signaling have not been characterized. Here, we studied the effects of ICI